Company · CIK 1622057
Nascent Biotech Inc.
| CIK | 1622057 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | FL |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-02-13 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277960 | 2024-03-15 | 2024-04-08 | 4 | |
| 333-267496 | 2022-09-19 | 2022-09-26 | 2 | |
| 333-251525 | 2020-12-18 | 2022-09-01 | 5 | |
| 333-233834 | 2019-09-19 | 2020-05-04 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-04-08 | EFFECTDeclared effective | 333-277960 | 9999999995-24-000889 |
| 2024-04-03 | S-1/AAmendment | 333-277960 | 0001477932-24-001853 |
| 2024-03-29 | S-1/AAmendment | 333-277960 | 0001477932-24-001608 |
| 2024-03-15 | S-1Registration filed | 333-277960 | 0001477932-24-001231 |
| 2022-09-26 | EFFECTDeclared effective | 333-267496 | 9999999995-22-002830 |
| 2022-09-19 | S-1Registration filed | 333-267496 | 0001477932-22-007021 |
| 2022-09-01 | EFFECTDeclared effective | 333-251525 | 9999999995-22-002567 |
| 2021-01-14 | EFFECTDeclared effective | 333-251525 | 9999999995-21-000150 |
| 2021-01-08 | S-1/AAmendment | 333-251525 | 0001477932-21-000116 |
| 2020-12-31 | S-1/AAmendment | 333-251525 | 0001477932-20-007602 |
| 2020-12-18 | S-1Registration filed | 333-251525 | 0001477932-20-007399 |
| 2020-05-04 | EFFECTDeclared effective | 333-233834 | 9999999995-20-001020 |
| 2019-10-31 | EFFECTDeclared effective | 333-233834 | 9999999995-19-002440 |
| 2019-10-16 | S-1/AAmendment | 333-233834 | 0001477932-19-005911 |
| 2019-09-19 | S-1Registration filed | 333-233834 | 0001477932-19-005466 |